Vimarsana
Biggest News Aggregation in the World

Page 21 - Venture Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Venture Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Venture Development Today - Breaking & Trending Today

A recap of all the new launch condos in 2021 - Vimarsana News

A recap of all the new launch condos in 2021

2021 has been an interesting year. Mask-wearing, SafeEntry and the changes in phases (we’ve lost count of how many times we’ve entered a new phase) remind us the pandemic hasn’t ended yet. At the same time, looking at the robust property market this year, it doesn’t feel like we’re in a pandemic anymore. Given the positive economic outlook, we’ve seen...

Nob Hill Therapeutics Announces Strategic Advisory Board to Accelerate Growth - Vimarsana News

Nob Hill Therapeutics Announces Strategic Advisory Board to Accelerate Growth

Albuquerque, NM (PRWEB) November 22, 2021 -- Nob Hill Therapeutics (NHT) is pleased to announce the members of its Strategic Advisory Board. Under the

Source: prweb.com
A high-tech vision - Vimarsana News

A high-tech vision

Jerry Adams has long had a vision for a high-tech Arkansas. It's one he's not giving up on even though Adams is now in his late 70s.

Akeso Biomedical Receives EU Authorization for CI-FER® as a Feed Additive in Piglets - Vimarsana News

Akeso Biomedical Receives EU Authorization for CI-FER® as a Feed Additive in Piglets

BURLINGTON, MA (PRWEB) October 25, 2021 -- Akeso Biomedical, Inc., announced today that the company has obtained authorization in the European Union to market

Source: prweb.com
Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic - Vimarsana News

Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic

Aurora, CO (PRWEB) October 14, 2021 -- Neurexis Therapeutics, Incorporated, announces it has been awarded a $496,145 grant from the National Institute of

Source: prweb.com